Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
Science
; 375(6578): eabl6251, 2022 01 21.
Article
in En
| MEDLINE
| ID: mdl-34855508
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Antibodies, Neutralizing
/
Immune Evasion
/
Spike Glycoprotein, Coronavirus
/
SARS-CoV-2
/
Antibodies, Viral
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Science
Year:
2022
Document type:
Article